Pelletier Amélie, Tardif Annie, Gingras Marie-Hélène, Chiasson Jean-Louis, Coderre Lise
Montreal Diabetes Research Centre, Centre hospitalier de l'Université de Montréal (CHUM)-Hôtel-Dieu, 3850 St. Urbain, Montreal, Que., Canada, H2W 1T7.
Mol Cell Biochem. 2007 Feb;296(1-2):97-108. doi: 10.1007/s11010-006-9303-7. Epub 2006 Sep 8.
There is a strong positive correlation between insulin resistance and cardiac diseases. We have already shown that chronic exposure to the ketone body beta-hydroxybutyrate (OHB) decreases insulin-mediated activation of protein kinase B (PKB) and glucose uptake in cardiomyocytes. To gain further insights into the mechanism underlying ketone body-induced insulin resistance, we examined whether OHB alters activation of the insulin-signaling cascade and whether the insulinomimetic agent vanadate could bypass insulin resistance and stimulate glucose uptake in these cells. Cardiomyocytes were incubated with 5 mM OHB, 50 microM vanadate or both for 16 h before the measurement of glucose uptake or the activation of insulin-signaling molecules. While chronic exposure to OHB did not alter insulin- or vanadate-mediated activation of the insulin receptor, it suppressed insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation in response to both agonists. Furthermore, this treatment decreased by 54 and 36% the phosphorylation of the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3-K) and PKB in response to insulin, whereas it did not alter vanadate-mediated activation of these enzymes. Although insulin did not significantly stimulate p38MAPK phosphorylation, vanadate increased it by 3.8-fold. Furthermore, chronic exposure to OHB potentiated vanadate's action, resulting in a 250% increase in enzyme activation compared to control cells. Though OHB induced a 2.1-fold increase of basal ERK1/2 phosphorylation, inhibition of this enzyme with the MEK inhibitor PD98059 demonstrated that ERK1/2 did not participate in OHB-induced insulin resistance. In conclusion, ketone bodies promote insulin resistance probably through decreased activation of the PI3-K/PKB signaling cascade. Furthermore, vanadate can bypass insulin resistance and stimulate glucose uptake in OHB-treated cardiomyocytes.
胰岛素抵抗与心脏疾病之间存在很强的正相关性。我们已经表明,长期暴露于酮体β-羟基丁酸酯(OHB)会降低胰岛素介导的蛋白激酶B(PKB)的激活以及心肌细胞对葡萄糖的摄取。为了进一步深入了解酮体诱导胰岛素抵抗的机制,我们研究了OHB是否会改变胰岛素信号级联反应的激活,以及胰岛素模拟剂钒酸盐是否可以绕过胰岛素抵抗并刺激这些细胞对葡萄糖的摄取。在测量葡萄糖摄取或胰岛素信号分子的激活之前,将心肌细胞与5 mM OHB、50 μM钒酸盐或两者一起孵育16小时。虽然长期暴露于OHB不会改变胰岛素或钒酸盐介导的胰岛素受体激活,但它会抑制胰岛素受体底物-1(IRS-1)对两种激动剂的酪氨酸磷酸化。此外,这种处理使胰岛素刺激下的磷脂酰肌醇3激酶(PI3-K)的p85调节亚基和PKB的磷酸化分别降低了54%和36%,而它不会改变钒酸盐介导的这些酶的激活。虽然胰岛素不会显著刺激p38MAPK磷酸化,但钒酸盐会使其增加3.8倍。此外,长期暴露于OHB会增强钒酸盐的作用,与对照细胞相比,酶激活增加了250%。虽然OHB使基础ERK1/2磷酸化增加了2.1倍,但用MEK抑制剂PD98059抑制该酶表明ERK1/2不参与OHB诱导的胰岛素抵抗。总之,酮体可能通过降低PI3-K/PKB信号级联反应的激活来促进胰岛素抵抗。此外,钒酸盐可以绕过胰岛素抵抗并刺激OHB处理的心肌细胞对葡萄糖的摄取。